Device Medical Device

Oncology Solution

Payments companies reported to CMS as associated with Oncology Solution. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$476associated payments (2023-2025)

26clinicians with associated payments

1company reporting

By year

2025 $476

Payments reported as associated with Oncology Solution, per program year, as reported to CMS.

Who makes it

Philips North America LLC $476 associated with Oncology Solution (2023-2025)

Specialties most often involved

Urology $308

Nurse Practitioner $36.72

Physician Assistant $35.40

Obstetrics & Gynecology $18.83

Family $14.38

Primary Care $14.38

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Oncology Solution

These are the largest totals companies reported as associated with Oncology Solution. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Richard Levin	Aventura, FL	Urology	$30.17
David Robbins	North Miami, FL	Urology	$23.45
Christopher Tallman	Coconut Creek, FL	Urology	$22.86
Darren Bryk	Coconut Creek, FL	Urology	$22.86
Jacob Parke	Coconut Creek, FL	Urology	$22.86
Thomas Suits	Stuart, FL		$19.53
Michael Tradewell	Stuart, FL	Urology	$19.53
Brandi Wilson	Vero Beach, FL	Obstetrics & Gynecology	$18.83
Joseph Crawford	Vero Beach, FL	Urology	$18.83
Michael Barrett	Vero Beach, FL	Nurse Practitioner	$18.83

Prescribed Oncology Solution?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.